Entered into a Definitive Merger Agreement
with XTI Aircraft;
Merger Expected to be Completed during the Fourth Quarter of
2023
Business Update Presentation with XTI Aircraft
Management
to be Held Today at 4:30 p.m.
ET
PALO
ALTO, Calif., Aug. 14,
2023 /PRNewswire/ -- Inpixon® (Nasdaq: INPX), a
leading provider of real-time location systems (RTLS), today
provided a business update and reported financial results for the
second quarter ended June 30,
2023.
"During the second quarter we continued our work to explore,
identify, and pursue strategic alternatives with the goal of
delivering additional value for our shareholders," commented
Nadir Ali, CEO of Inpixon. "Towards
this end, we're excited to have recently announced entering into a
definitive merger agreement with XTI Aircraft, an innovative
aviation company developing a vertical lift crossover airplane
(VLCA). We believe this transaction will be transformational for
Inpixon and XTI, resulting in a public company that will be engaged
in both advancing the TriFan 600, a fixed wing, vertical takeoff
and landing (VTOL) aircraft, and in offering RTLS solutions to
industrial markets. With over 700 conditional pre-orders[1],
representing the potential for gross revenues of approximately
$7.1 billion[2], we believe there is
a strong demand for the TriFan 600, and a compelling opportunity
for Inpixon and its stockholders. We are enthusiastic about the
potential of the combined company and anticipate closing the
transaction during the fourth quarter of 2023.
"Inpixon improved its gross margins during the quarter as a
result of lower cost of goods within the IIoT and SAVES business
lines. With RTLS enabling customers to digitally track the location
of assets, our customers can locate, learn, and leverage
information to make data-driven business decisions. In addition, we
have preserved a solid balance sheet with over $15.7 million in cash and cash equivalents as of
June 30, 2023. Overall, we believe we
are undertaking activities that have the potential to provide
additional value for shareholders, and I would strongly encourage
all our investors to participate in the business update
presentation this afternoon, which will include an overview of XTI
provided by its management team," concluded Mr. Ali.
[1] Conditional pre-orders refers to a combination of aircraft
purchase agreements, non-binding reservation deposit agreements,
and options.
[2] Based on XTI's current list price of $10 million per aircraft and assuming XTI is able
to execute on the development program for the TriFan, secure FAA
certification, and deliver the aircrafts.
Financial Results
Revenues for the three and six months ended June 30, 2023 were $2.1
million and $5.2 million,
respectively, compared to $2.6
million and $5.2 million,
respectively, for the comparable periods in the prior year. This
quarter-over-quarter decrease was primarily attributable to the
decrease in Indoor Intelligence sales due to delayed shipments and
lower sales for the SAVES product line. Gross profit for the three
and six months ended June 30, 2023
was $1.7 million and $4.0 million, respectively, compared to
$1.7 million and $3.6 million for the 2022 respective periods. The
gross profit margin for the three and six months ended June 30, 2023, was 81% and 77%, compared to 67%
and 68% for the three and six months ended June 30, 2022, respectively. This increase in
gross margin was primarily due to the lower cost of revenues on the
SAVES product line.
Operating expenses for the three months ended June 30, 2023 were $8.3
million and $11.1 million for
the comparable period ended June 30,
2022. This decrease of approximately $2.8 million is primarily attributable to the
$2.0 million of goodwill impairment
in the three months ended June 30,
2022 and lower compensation, professional fees and legal
expenses in the three months ended June 30,
2023. Operating expenses for the six months ended
June 30, 2023 were $18.8 million and $22.2
million for the comparable period ended June 30, 2022. This decrease of $3.4 million is primarily attributable to the
$2.0 million of goodwill impairment
in the six months ended June 30,
2022, lower stock-based compensation and professional fees
in the six months ended June 30, 2023
offset by $1.4 million of transaction
costs in the 2023 period.
Net loss from continuing operations for the three months ended
June 30, 2023 was $7.33 million compared to $8.97 million for the comparable period in the
prior year. This decrease in loss of approximately $1.6 million was primarily attributable to the
goodwill impairment of $2.0 million
in the three months ended June 30,
2022 and lower operating expenses in the three months ended
June 30, 2023. Net loss from
continuing operations for both the six months ended June 30, 2023 and 2022, was $19.7 million. Non-GAAP Adjusted EBITDA for the
three and six months ended June 30,
2023 was a loss of $5.0
million and $9.9 million,
respectively, compared to a loss of $5.2
million and $11.7 million for
the prior year periods, respectively. Non-GAAP Adjusted EBITDA is
defined as net income or loss before interest, provision for income
taxes, depreciation and amortization plus adjustments for other
income or expense items, non-recurring items and non-cash items
including stock-based compensation.
Proforma non-GAAP net loss per basic and diluted common share
for the three and six months ended June 30,
2023 was a loss of $0.18 and
$0.79, respectively, compared to a
loss of $2.72 and $5.88 for the prior year periods. Non-GAAP net
loss per share is defined as net loss per basic and diluted share
adjusted for non-cash items including stock-based compensation,
amortization of intangibles and one-time charges and other
adjustments including impairment of goodwill, provision for
valuation allowance on notes, and acquisition costs.
Conference Call and Presentation Information
Inpixon will host a conference call presentation today at
4:30 p.m. ET to provide a business
update as well as a presentation by the management of XTI
Aircraft Company ("XTI") following the recently
announced definitive merger agreement between Inpixon and
XTI.
Interested parties may access the conference call presentation
at https://www.webcaster4.com/Webcast/Page/2235/48894 or
at the link on Inpixon's Investor Relations section of the
website, ir.inpixon.com/ir-news-events/ir-calendar. A
webcast replay will be available on Inpixon's Investor Relations
section of the website
(ir.inpixon.com/ir-news-events/ir-calendar).
Shareholders and other interested parties are invited to submit
questions to Inpixon management via email
to inpx@crescendo-ir.com.
About Inpixon
Inpixon® (Nasdaq: INPX) is the innovator of Indoor
Intelligence®, delivering actionable insights for
people, places and things. Combining the power of mapping,
positioning and analytics, Inpixon helps to create smarter, safer,
and more secure environments. The company's Indoor Intelligence and
industrial real-time location system (RTLS) solutions are leveraged
by a multitude of industries to optimize operations, increase
productivity, and enhance safety. Inpixon customers can take
advantage of industry leading location awareness, analytics, sensor
fusion, IIoT and the IoT to create exceptional experiences and to
do good with indoor data. For the latest insights, follow Inpixon
on LinkedIn, and Twitter, and visit inpixon.com.
About XTI
XTI Aircraft Company is an aviation business based near
Denver, Colorado. XTI is guided by
a leadership team with decades of experience, deep expertise, and
success bringing new aircraft to market, including more than 40
FAA-certified new aircraft configurations. XTI is founded on a
culture of customer-focused problem solving to meet the evolving
needs of modern travelers. For information and updates about XTI
Aircraft Company and the TriFan 600, visit xtiaircraft.com. For
information on reserving a priority position for the TriFan under
the company's pre-sales program, contact Mr. Saleem Zaheer at +1-720-900-6928 or
szaheer@xtiaircraft.com.
Non-GAAP Financial Measures
Management believes that certain financial measures not in
accordance with generally accepted accounting principles in
the United States ("GAAP") are
useful measures of operations. EBIDTA, Adjusted EBITDA and pro
forma net loss per share are non-GAAP measures. Inpixon defines
"EBITDA" as net income (loss) before interest, provision for
(benefit from) income taxes, and depreciation and amortization.
Management uses Adjusted EBITDA as a metric for which it manages
the business, and Inpixon defines "Adjusted EBITDA" as EBITDA plus
adjustments for other income or expense items, non-recurring items
and non-cash items. Inpixon defines "pro forma net loss per share"
as GAAP net loss per share adjusted for stock-based compensation,
amortization of intangibles and one-time charges including
impairment of goodwill and gain on equity securities.
Management provides Adjusted EBITDA and pro forma net loss per
share measures so that investors will have the same financial
information that management uses, which may assist investors in
assessing Inpixon's performance on a period-over-period basis.
Adjusted EBITDA or pro forma net loss per share is not a measure of
financial performance under GAAP and should not be considered an
alternative to net income (loss) or any other measure of
performance under GAAP, or to cash flows from operating, investing
or financing activities as an indicator of cash flows or as a
measure of liquidity. Adjusted EBITDA and pro forma net loss per
share have limitations as analytical tools and should not be
considered either in isolation or as a substitute for analysis of
Inpixon's results as reported under GAAP.
For more information on our non-GAAP financial measures and a
reconciliation of GAAP to non-GAAP measures, please see the
"Reconciliation of Non-GAAP Financial Measures" table accompanying
this press release.
Contacts
Inpixon Contacts
General
inquiries:
Email: marketing@inpixon.com
Web: inpixon.com/contact-us
Investor relations:
Crescendo Communications for Inpixon
Tel: +1 212-671-1020
Email: INPX@crescendo-ir.com
XTI Aircraft Contacts
General
inquiries:
Email: liftup@xtiaircraft.com
Web: xtiaircraft.com/cm/get-involved
Investor relations:
Crescendo Communications for
XTI
Tel: +1 212-671-1020
Email: XTI@crescendo-ir.com
Important Information About the Proposed Transaction and
Where to Find It
This press release relates to a proposed transaction between XTI
Aircraft Company, a Delaware
corporation ("XTI"), and Inpixon, a Nevada corporation ("Inpixon"), pursuant to an
agreement and plan of merger, dated as of July 24, 2023, by and among Inpixon, Superfly
Merger Sub Inc. and XTI (the "proposed transaction"). Inpixon has
filed a registration statement on Form S-4 (the "Form S-4") with
the U.S. Securities and Exchange Commission ("SEC"), which includes
a preliminary prospectus and proxy statement of Inpixon in
connection with the proposed transaction, referred to as a proxy
statement/prospectus. A proxy statement/prospectus will be sent to
all Inpixon stockholders as of a record date to be established for
voting on the transaction and to the stockholders of XTI. Inpixon
will also file other documents regarding the proposed transaction
with the SEC.
Before making any voting decision, investors and security
holders are urged to read the registration statement, the proxy
statement/prospectus, and amendments thereto, and the definitive
proxy statement/prospectus in connection with Inpixon's
solicitation of proxies for its stockholders' meeting to be held to
approve the transaction, and all other relevant documents filed or
that will be filed with the SEC in connection with the proposed
transaction as they become available because they will contain
important information about Inpixon, XTI and the proposed
transaction.
Investors and securityholders will be able to obtain free copies
of the registration statement, the proxy statement/prospectus and
all other relevant documents filed or that will be filed with the
SEC by Inpixon through the website maintained by the SEC
at www.sec.gov.
The documents filed by Inpixon with the SEC also may be obtained
free of charge at Inpixon's website at www.inpixon.com or
upon written request to: Inpixon, 2479 E. Bayshore Road, Suite 195,
Palo Alto, CA 94303.
NEITHER THE SEC NOR ANY STATE SECURITIES REGULATORY AGENCY HAS
APPROVED OR DISAPPROVED THE TRANSACTIONS DESCRIBED IN THIS
COMMUNICATION, PASSED UPON THE MERITS OR FAIRNESS OF THE
TRANSACTION OR RELATED TRANSACTIONS OR PASSED UPON THE ADEQUACY OR
ACCURACY OF THE DISCLOSURE IN THIS COMMUNICATION. ANY
REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL OFFENSE.
Forward-Looking Statements
This communication contains certain "forward-looking statements"
within the meaning of the United States Private Securities
Litigation Reform Act of 1995, Section 27A of the Securities Act of
1933, as amended (the "Securities Act"), and Section 21E of the
Securities Exchange Act of 1934, as amended. All statements other
than statements of historical fact contained in this communication,
including statements regarding the benefits of the proposed
transaction, the anticipated timing of the completion of the
proposed transaction, the products under development by XTI and the
markets in which it plans to operate, the advantages of XTI's
technology, XTI's competitive landscape and positioning, and XTI's
growth plans and strategies, are forward-looking statements.
Some of these forward-looking statements can be identified by
the use of forward-looking words, including "may," "should,"
"expect," "intend," "will," "estimate," "anticipate," "believe,"
"predict," "plan," "targets," "projects," "could," "would,"
"continue," "forecast" or the negatives of these terms or
variations of them or similar expressions. All forward-looking
statements are subject to risks, uncertainties, and other factors
which could cause actual results to differ materially from those
expressed or implied by such forward-looking statements. All
forward-looking statements are based upon estimates, forecasts and
assumptions that, while considered reasonable by Inpixon and its
management, and XTI and its management, as the case may be, are
inherently uncertain and many factors may cause the actual results
to differ materially from current expectations which include, but
are not limited to:
- the risk that the proposed transaction may not be completed in
a timely manner or at all, which may adversely affect the price of
Inpixon's securities;
- the failure to satisfy the conditions to the consummation of
the proposed transaction, including the adoption of the merger
agreement by the shareholders of Inpixon;
- the occurrence of any event, change or other circumstance that
could give rise to the termination of the merger agreement;
- the adjustments permitted under the merger agreement to the
exchange ratio that could result in XTI shareholders or Inpixon
shareholders owning less of the post-combination company than
expected;
- the effect of the announcement or pendency of the proposed
transaction on Inpixon's and XTI's business relationships,
performance, and business generally;
- risks that the proposed transaction disrupts current plans of
Inpixon and XTI and potential difficulties in Inpixon's and XTI's
employee retention as a result of the proposed transaction;
- the outcome of any legal proceedings that may be instituted
against XTI or against Inpixon related to the merger agreement or
the proposed transaction;
- failure to realize the anticipated benefits of the proposed
transaction;
- the inability to meet and maintain the listing of Inpixon's
securities (or the securities of the post-combination company) on
Nasdaq;
- the risk that the price of Inpixon's securities (or the
securities of the postcombination company) may be volatile due to a
variety of factors, including changes in the highly competitive
industries in which Inpixon and XTI operate,
- the inability to implement business plans, forecasts, and other
expectations after the completion of the proposed transaction, and
identify and realize additional opportunities;
- variations in performance across competitors, changes in laws,
regulations, technologies that may impose additional costs and
compliance burdens on Inpixon and XTI's operations, global supply
chain disruptions and shortages,
- national security tensions, and macro-economic and social
environments affecting Inpixon and XTI's business and changes in
the combined capital structure;
- the risk that XTI has a limited operating history, has not yet
manufactured any non-prototype aircraft or delivered any aircraft
to a customer, and XTI and its current and future collaborators may
be unable to successfully develop and market XTI's aircraft or
solutions, or may experience significant delays in doing so;
- the risk that XTI is subject to the uncertainties associated
with the regulatory approvals of its aircraft including the
certification by the Federal Aviation Administration, which is a
lengthy and costly process;
- the risk that the post-combination company may never achieve or
sustain profitability;
- the risk that XTI, Inpixon and the post-combination company may
be unable to raise additional capital on acceptable terms to
finance its operations and remain a going concern;
- the risk that the post-combination company experiences
difficulties in managing its growth and expanding operations;
- the risk that XTI's conditional pre orders (which include
conditional aircraft purchase agreements, non-binding reservations,
and options) are canceled, modified, delayed or not placed and that
XTI must return the refundable deposits;
- the risks relating to long development and sales cycles, XTI's
ability to satisfy the conditions and deliver on the orders and
reservations, its ability to maintain quality control of its
aircraft, and XTI's dependence on third parties for supplying
components and potentially manufacturing the aircraft;
- the risk that other aircraft manufacturers develop competitive
VTOL aircraft or other competitive aircraft that adversely affect
XTI's market position;
- the risk that XTI's future patent applications may not be
approved or may take longer than expected, and XTI may incur
substantial costs in enforcing and protecting its intellectual
property;
- the risk that XTI's estimates of market demand may be
inaccurate;
- the risk that XTI's ability to sell its aircraft may be limited
by circumstances beyond its control, such as a shortage of pilots
and mechanics who meet the training standards, high maintenance
frequencies and costs for the sold aircraft, and any accidents or
incidents involving VTOL aircraft that may harm customer
confidence;
- other risks and uncertainties set forth in the sections
entitled "Risk Factors" and "Cautionary Note Regarding
Forward-Looking Statements" in Inpixon's Annual Report on Form 10-K
for the year ended December, 31, 2022, which was filed with the SEC
on April 17, 2023 (the "2022 Form
10-K") and Quarterly Report on Form 10-Q for the quarterly period
ended March 31, 2023 filed on
May 16, 2023, and in the section
entitled "Risk Factors" in XTI's periodic reports filed pursuant to
Regulation A of the Securities Act including XTI's Annual Report on
Form 1-K for the year ended December 31,
2022, which was filed with the SEC on July 13, 2023 (the "2022 Form 1-K"), as such
factors may be updated from time to time in Inpixon's and XTI's
filings with the SEC, the registration statement on Form S-4 and
the proxy statement/prospectus contained therein. These filings
identify and address other important risks and uncertainties that
could cause actual events and results to differ materially from
those contained in the forward-looking statements.
Nothing in this press release should be regarded as a
representation by any person that the forward-looking statements
set forth herein will be achieved or that any of the contemplated
results of such forward-looking statements will be achieved. You
should not place undue reliance on forward-looking statements,
which speak only as of the date they are made. Neither Inpixon nor
XTI gives any assurance that either Inpixon or XTI or the
post-combination company will achieve its expected results. Neither
Inpixon nor XTI undertakes any duty to update these forward-looking
statements, except as otherwise required by law.
Participants in the Solicitation
XTI and Inpixon and their respective directors and officers and
other members of management may, under SEC rules, be deemed to be
participants in the solicitation of proxies from Inpixon's
stockholders with the proposed transaction and the other matters
set forth in the registration statement. Information about
Inpixon's and XTI's directors and executive officers is set forth
in Inpixon's filings and XTI's filings with the SEC, including
Inpixon's 2022 Form 10-K and XTI's 2022 Form 1-K. Additional
information regarding the direct and indirect interests, by
security holdings or otherwise, of those persons and other persons
who may be deemed participants in the proposed transaction may be
obtained by reading the proxy statement/prospectus regarding the
proposed transaction when it becomes available. You may obtain free
copies of these documents as described above under "Important
Information About the Proposed Transaction and Where to Find
It."
No Offer or Solicitation
This press release is not a proxy statement or solicitation of a
proxy, consent or authorization with respect to any securities or
in respect of the proposed transaction and is not intended to and
does not constitute an offer to sell or the solicitation of an
offer to buy, sell or solicit any securities or any proxy, vote or
approval, nor shall there be any sale of securities in any
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such jurisdiction. No offer of securities
shall be deemed to be made except by means of a prospectus meeting
the requirements of Section 10 of the Securities Act.
INPIXON AND SUBSIDIARIES
|
CONDENSED CONSOLIDATED BALANCE
SHEETS
|
(In thousands, except number of shares and par value
data)
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
June 30,
2023
|
|
|
December 31,
2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
(Audited)
|
ASSETS
|
|
|
|
|
Current Assets
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
15,681
|
|
$
|
10,235
|
Accounts receivable,
net of allowances of $237 and $272, respectively
|
|
|
1,803
|
|
|
1,889
|
Notes and other
receivables
|
|
|
785
|
|
|
86
|
Inventory
|
|
|
3,228
|
|
|
2,442
|
Note
receivable
|
|
|
--
|
|
|
150
|
Prepaid assets and
other current assets
|
|
|
2,181
|
|
|
2,803
|
Current assets of
discontinued operations
|
|
|
--
|
|
|
12,261
|
Total Current Assets
|
|
|
23,678
|
|
|
29,866
|
|
|
|
|
|
|
|
Property and equipment,
net
|
|
|
1,009
|
|
|
1,064
|
Operating lease
right-of-use asset, net
|
|
|
434
|
|
|
531
|
Software development
costs, net
|
|
|
1,113
|
|
|
1,265
|
Investment in equity
securities
|
|
|
1,414
|
|
|
330
|
Long-term
investments
|
|
|
50
|
|
|
716
|
Intangible assets,
net
|
|
|
2,573
|
|
|
2,994
|
Other assets
|
|
|
174
|
|
|
158
|
Non-current assets of
discontinued operations
|
|
|
--
|
|
|
20,711
|
Total Assets
|
|
$
|
30,445
|
|
$
|
57,635
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS'
EQUITY
|
|
|
|
|
|
|
Current Liabilities
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
1,665
|
|
$
|
1,503
|
Accrued
liabilities
|
|
|
5,374
|
|
|
2,619
|
Operating lease
obligation, current
|
|
|
200
|
|
|
211
|
Deferred
revenue
|
|
|
1,124
|
|
|
1,323
|
Short-term
debt
|
|
|
13,800
|
|
|
13,643
|
Acquisition
liability
|
|
|
--
|
|
|
197
|
Warrant
Liability
|
|
|
1,500
|
|
|
--
|
Current liabilities of
discontinued operations
|
|
|
--
|
|
|
5,218
|
Total Current Liabilities
|
|
|
23,663
|
|
|
24,714
|
|
|
|
|
|
|
|
Long Term Liabilities
|
|
|
|
|
|
|
Operating lease
obligations, noncurrent
|
|
|
245
|
|
|
334
|
Non-current liabilities
of discontinued operations
|
|
|
--
|
|
|
472
|
Total Liabilities
|
|
|
23,908
|
|
|
25,520
|
|
|
|
|
|
|
|
Commitments and Contingencies
|
|
|
--
|
|
|
--
|
|
|
|
|
|
|
|
Stockholders' Equity
|
|
|
|
|
|
|
Preferred Stock -
$0.001 par value; 5,000,000 shares authorized.
|
|
|
|
|
|
|
Series 4 Convertible
Preferred Stock - 10,415 shares authorized; 1 issued and 1
outstanding as of June 30, 2023 and December 31, 2022,
respectively;
|
|
|
--
|
|
|
--
|
Series 5 Convertible
Preferred Stock - 12,000 shares authorized; 126 issued and 126
outstanding as of June 30, 2023 and December 31, 2022,
respectively.
|
|
|
--
|
|
|
--
|
Common Stock - $0.001
par value; 500,000,000 shares authorized; 43,154,195 and 3,570,894
issued and 43,154,194 and 3,570,893 outstanding as of June 30, 2023
and December 31, 2022, respectively.
|
|
|
43
|
|
|
4
|
Additional paid-in
capital
|
|
|
346,799
|
|
|
346,668
|
Treasury stock, at
cost, 1 share
|
|
|
(695)
|
|
|
(695)
|
Accumulated other
comprehensive (loss) income
|
|
|
(189)
|
|
|
1,061
|
Accumulated
deficit
|
|
|
(337,555)
|
|
|
(313,739)
|
Stockholders' Equity
Attributable to Inpixon
|
|
|
8,403
|
|
|
33,299
|
|
|
|
|
|
|
|
Non-controlling
interest
|
|
|
(1,866)
|
|
|
(1,184)
|
|
|
|
|
|
|
|
Total Stockholders' Equity
|
|
|
6,537
|
|
|
32,115
|
|
|
|
|
|
|
|
Total Liabilities and Stockholders'
Equity
|
|
$
|
30,445
|
|
$
|
57,635
|
INPIXON AND SUBSIDIARIES
|
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE LOSS
|
(In thousands, except share and per share
data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended
|
|
|
For the Six Months
Ended
|
|
|
June 30,
|
|
|
June 30,
|
|
|
2023
|
|
2022
|
|
|
2023
|
|
2022
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
2,057
|
|
$
|
2,576
|
|
|
$
|
5,161
|
|
$
|
5,225
|
Cost of Revenues
|
|
|
390
|
|
|
856
|
|
|
|
1,180
|
|
|
1,653
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
1,667
|
|
|
1,720
|
|
|
|
3,981
|
|
|
3,572
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and
development
|
|
|
2,051
|
|
|
2,482
|
|
|
|
4,033
|
|
|
4,576
|
Sales and
marketing
|
|
|
1,241
|
|
|
754
|
|
|
|
2,357
|
|
|
1,924
|
General and
administrative
|
|
|
4,236
|
|
|
5,294
|
|
|
|
9,850
|
|
|
12,658
|
Acquisition related
costs
|
|
|
523
|
|
|
137
|
|
|
|
687
|
|
|
252
|
Transaction
costs
|
|
|
43
|
|
|
--
|
|
|
|
1,443
|
|
|
--
|
Impairment of
goodwill
|
|
|
--
|
|
|
2,030
|
|
|
|
--
|
|
|
2,030
|
Amortization of
intangibles
|
|
|
230
|
|
|
396
|
|
|
|
450
|
|
|
743
|
Total Operating Expenses
|
|
|
8,324
|
|
|
11,093
|
|
|
|
18,820
|
|
|
22,183
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from Operations
|
|
|
(6,657)
|
|
|
(9,373)
|
|
|
|
(14,839)
|
|
|
(18,611)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (Expense) Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest (expense)/
income, net
|
|
|
(1,756)
|
|
|
168
|
|
|
|
(3,481)
|
|
|
169
|
Other income/(expense),
net
|
|
|
1,183
|
|
|
15
|
|
|
|
1,212
|
|
|
(28)
|
Unrealized gain/(loss)
on equity securities
|
|
|
(92)
|
|
|
247
|
|
|
|
(58)
|
|
|
(1,256)
|
Total Other Expense
|
|
|
(665)
|
|
|
430
|
|
|
|
(2,327)
|
|
|
(1,115)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss from Continuing Operations, before
tax
|
|
|
(7,322)
|
|
|
(8,943)
|
|
|
|
(17,166)
|
|
|
(19,726)
|
Income tax
provision
|
|
|
(7)
|
|
|
(22)
|
|
|
|
(2,485)
|
|
|
(22)
|
Net Loss from Continuing
Operations
|
|
|
(7,329)
|
|
|
(8,965)
|
|
|
|
(19,651)
|
|
|
(19,748)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from Discontinued
Operations, Net of Tax
|
|
|
--
|
|
|
(11,365)
|
|
|
|
(4,856)
|
|
|
(12,139)
|
Net
Loss
|
|
|
(7,329)
|
|
|
(20,330)
|
|
|
|
(24,507)
|
|
|
(31,887)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss Attributable to Non-controlling
Interest
|
|
|
(363)
|
|
|
(458)
|
|
|
|
(667)
|
|
|
(804)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss Attributable to Stockholders of
Inpixon
|
|
$
|
(6,966)
|
|
$
|
(19,872)
|
|
|
$
|
(23,840)
|
|
$
|
(31,083)
|
Accretion of Series 7
preferred stock
|
|
|
--
|
|
|
--
|
|
|
|
--
|
|
|
(4,555)
|
Accretion of Series 8
Preferred Stock
|
|
|
--
|
|
|
(6,237)
|
|
|
|
--
|
|
|
(6,785)
|
Deemed dividend for the
modification related to Series 8 Preferred Stock
|
|
|
--
|
|
|
--
|
|
|
|
--
|
|
|
(2,627)
|
Deemed contribution for
the modification related to Warrants issued in connection with
Series 8 Preferred Stock
|
|
|
--
|
|
|
--
|
|
|
|
--
|
|
|
1,469
|
Amortization premium-
modification related to Series 8 Preferred Stock
|
|
|
--
|
|
|
1,252
|
|
|
|
--
|
|
|
1,362
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss Attributable to Common
Stockholders
|
|
$
|
(6,966)
|
|
$
|
(24,857)
|
|
|
$
|
(23,840)
|
|
$
|
(42,219)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss Per Share - Basic and
Diluted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing
Operations
|
|
$
|
(0.19)
|
|
$
|
(6.99)
|
|
|
$
|
(0.92)
|
|
$
|
(14.90)
|
Discontinued
Operations
|
|
$
|
--
|
|
$
|
(5.88)
|
|
|
$
|
(0.24)
|
|
$
|
(6.01)
|
Net Loss Per Share - Basic and
Diluted
|
|
$
|
(0.19)
|
|
$
|
(12.87)
|
|
|
$
|
(1.16)
|
|
$
|
(20.91)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average Shares
Outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and
Diluted
|
|
|
37,442,387
|
|
|
1,931,535
|
|
|
|
20,600,208
|
|
|
2,018,295
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive Loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss
|
|
$
|
(7,329)
|
|
$
|
(20,330)
|
|
|
$
|
(24,507)
|
|
$
|
(31,887)
|
Unrealized gain on
available for sale debt securities
|
|
|
--
|
|
|
375
|
|
|
|
--
|
|
|
375
|
Unrealized foreign
exchange loss from cumulative translation adjustments
|
|
|
9
|
|
|
281
|
|
|
|
(1,250)
|
|
|
180
|
Comprehensive Loss
|
|
$
|
(7,320)
|
|
$
|
(19,674)
|
|
|
$
|
(25,757)
|
|
$
|
(31,332)
|
INPIXON AND SUBSIDIARIES
|
CONSOLIDATED CONSOLIDATED STATEMENTS OF CASH
FLOWS
|
(In thousands)
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended
|
|
|
June 30,
|
|
|
2023
|
|
2022
|
(Unaudited)
|
Cash Flows Used In Operating
Activities
|
|
|
|
|
|
|
Net
loss
|
|
$
|
(24,507)
|
|
$
|
(31,887)
|
Adjustments to
reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
624
|
|
|
650
|
Amortization of
intangible assets
|
|
|
1,255
|
|
|
3,026
|
Amortization of right
of use asset
|
|
|
158
|
|
|
353
|
Stock based
compensation
|
|
|
570
|
|
|
2,274
|
Amortization of warrant
liability to redemption value
|
|
|
20
|
|
|
--
|
Earnout expense
valuation benefit
|
|
|
--
|
|
|
(2,827)
|
Gain on settlement with
FOXO
|
|
|
(1,142)
|
|
|
--
|
Amortization of debt
issuance costs
|
|
|
1,686
|
|
|
(92)
|
Unrealized gain on
note
|
|
|
--
|
|
|
344
|
Unrealized loss on
foreign currency transactions
|
|
|
(178)
|
|
|
--
|
Distribution of equity
method investment shares to employees as compensation
|
|
|
666
|
|
|
--
|
Deferred income
tax
|
|
|
2,591
|
|
|
(1)
|
Unrealized loss on
equity securities
|
|
|
58
|
|
|
1,256
|
Impairment of
goodwill
|
|
|
--
|
|
|
7,570
|
Gain on fair value of
warrant liability
|
|
|
71
|
|
|
--
|
Other
|
|
|
22
|
|
|
181
|
|
|
|
|
|
|
|
Changes in operating
assets and liabilities:
|
|
|
|
|
|
|
Accounts receivable and
other receivables
|
|
|
(1,016)
|
|
|
361
|
Inventory
|
|
|
(779)
|
|
|
285
|
Prepaid expenses and
other current assets
|
|
|
890
|
|
|
1,357
|
Other assets
|
|
|
(4)
|
|
|
25
|
Accounts
payable
|
|
|
(634)
|
|
|
(1,498)
|
Accrued
liabilities
|
|
|
3,796
|
|
|
542
|
Income tax
liabilities
|
|
|
(119)
|
|
|
(40)
|
Deferred
revenue
|
|
|
325
|
|
|
(1,096)
|
Operating lease
obligation
|
|
|
(158)
|
|
|
(327)
|
Net Cash Used in Operating
Activities
|
|
$
|
(15,805)
|
|
$
|
(19,544)
|
|
|
|
|
|
|
|
Cash Flows Used in Investing
Activities
|
|
|
|
|
|
|
Purchase
of property and equipment
|
|
|
(45)
|
|
|
(140)
|
Investment in
capitalized software
|
|
|
(135)
|
|
|
(306)
|
Purchase of convertible
note
|
|
|
--
|
|
|
(5,500)
|
Sales of treasury
bills
|
|
|
--
|
|
|
43,001
|
Proceeds from repayment
of note receivable
|
|
|
150
|
|
|
--
|
Issuance of note
receivable
|
|
|
(450)
|
|
|
--
|
Net Cash (Used in) Provided By Investing
Activities
|
|
$
|
(480)
|
|
$
|
37,055
|
|
|
|
|
|
|
|
Cash From Financing Activities
|
|
|
|
|
|
|
Net proceeds from
issuance of preferred stock and warrants
|
|
$
|
--
|
|
|
46,906
|
Net proceeds from
promissory note
|
|
|
125
|
|
|
364
|
Net proceeds from
ATM
|
|
|
20,383
|
|
|
--
|
Cash paid for
redemption of preferred stock series 7
|
|
|
--
|
|
|
(49,250)
|
Taxes paid related to
net share settlement of restricted stock units
|
|
|
--
|
|
|
(336)
|
Net proceeds from
issuance of warrants
|
|
|
1,409
|
|
|
--
|
Repayment of CXApp
acquisition liability
|
|
|
(197)
|
|
|
(1,847)
|
Common shares issued
for net proceeds from warrants
|
|
|
1
|
|
|
--
|
Distribution to
shareholders related to spin-off of CXApp
|
|
|
(10,003)
|
|
|
--
|
Net Cash Provided By (Used in) Financing
Activities
|
|
$
|
11,718
|
|
$
|
(4,163)
|
|
|
|
|
|
|
|
Effect of Foreign Exchange Rate on Changes on
Cash
|
|
|
13
|
|
|
(73)
|
|
|
|
|
|
|
|
Net (Decrease) Increase in Cash and Cash
Equivalents
|
|
|
(4,554)
|
|
|
13,275
|
|
|
|
|
|
|
|
Cash and Cash
Equivalents - Beginning of year
|
|
|
20,235
|
|
|
52,480
|
|
|
|
|
|
|
|
Cash and Cash
Equivalents - End of year
|
|
$
|
15,681
|
|
$
|
65,755
|
Reconciliation of Non-GAAP Financial
Measures:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the 3 Months Ended
|
|
For the 6 Months Ended
|
(In
thousands)
|
|
June 30,
|
|
June 30,
|
|
2023
|
|
2022
|
|
2023
|
|
2022
|
|
|
|
|
|
|
|
|
|
Net loss attributable
to common stockholders
|
|
$ (6,966)
|
|
$
(24,857)
|
|
$
(23,840)
|
|
$
(42,219)
|
Loss from discontinued
operations, net of tax
|
|
-
|
|
11,365
|
|
4,856
|
|
12,139
|
Interest
expense/(income), net
|
|
1,756
|
|
(168)
|
|
3,481
|
|
(169)
|
Income tax
provision
|
|
7
|
|
22
|
|
2,485
|
|
22
|
Depreciation and
amortization
|
|
425
|
|
737
|
|
844
|
|
1,418
|
EBITDA
|
|
(4,778)
|
|
(12,901)
|
|
(12,174)
|
|
(28,809)
|
Adjusted for:
|
|
|
|
|
|
|
|
|
Non-recurring one-time
charges:
|
|
|
|
|
|
|
|
|
Unrealized (gain)/loss
on equity securities
|
|
92
|
|
(247)
|
|
58
|
|
1,256
|
Acquisition
transaction/financing costs
|
|
523
|
|
137
|
|
687
|
|
252
|
Professional service
fees
|
|
-
|
|
-
|
|
-
|
|
8
|
Impairment of
goodwill
|
|
-
|
|
2,030
|
|
-
|
|
2,030
|
Transaction costs
|
|
43
|
|
-
|
|
1,443
|
|
-
|
Accretion of series 7
preferred stock
|
|
-
|
|
-
|
|
-
|
|
4,555
|
Accretion of series 8
preferred stock
|
|
-
|
|
6,237
|
|
-
|
|
6,785
|
Deemed dividend for the
modification related to Series 8 preferred stock
|
|
-
|
|
-
|
|
-
|
|
2,627
|
Deemed contribution for
the modification related to warrants issued in connection with the
Series 8 Preferred Stock
|
|
-
|
|
-
|
|
-
|
|
(1,469)
|
Amortization premium -
modification to Series 8 preferred stock
|
|
-
|
|
(1,252)
|
|
-
|
|
(1,362)
|
Distribution of
equity method investment shares to employees as
compensation
|
|
-
|
|
-
|
|
666
|
|
-
|
Gain on equity
securities
|
|
(1,142)
|
|
-
|
|
(1,142)
|
|
-
|
Unrealized foreign
exchange (gains)/losses
|
|
28
|
|
35
|
|
(145)
|
|
124
|
Bad debts
expense/provision
|
|
24
|
|
-
|
|
24
|
|
-
|
Reserve for inventory
obsolescence
|
|
16
|
|
-
|
|
16
|
|
-
|
Stock-based
compensation – compensation and related benefits
|
|
241
|
|
741
|
|
570
|
|
2,274
|
Severance
costs
|
|
-
|
|
-
|
|
127
|
|
62
|
Adjusted
EBITDA
|
|
$ (4,953)
|
|
$
(5,220)
|
|
$ (9,870)
|
|
$
(11,667)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the 3 Months Ended
|
|
For the 6 Months Ended
|
(In thousands, except
share data)
|
|
June 30,
|
|
June 30,
|
|
2023
|
|
2022
|
|
2023
|
|
2022
|
|
|
|
|
|
|
|
|
|
Net loss attributable
to common stockholders
|
|
$ (6,966)
|
|
$
(24,857)
|
|
$
(23,840)
|
|
$
(42,219)
|
Adjustments:
|
|
|
|
|
|
|
|
|
Non-recurring one-time
charges:
|
|
|
|
|
|
|
|
|
Loss from discontinued
operations, net of tax
|
|
-
|
|
11,365
|
|
4,856
|
|
12,139
|
Unrealized (gain)/loss
on equity securities
|
|
92
|
|
(247)
|
|
58
|
|
1,256
|
Acquisition
transaction/financing costs
|
|
523
|
|
137
|
|
687
|
|
252
|
Professional service
fees
|
|
-
|
|
-
|
|
-
|
|
8
|
Impairment of
goodwill
|
|
-
|
|
2,030
|
|
-
|
|
2,030
|
Transaction costs
|
|
43
|
|
-
|
|
1,443
|
|
-
|
Accretion of series 7
preferred stock
|
|
-
|
|
-
|
|
-
|
|
4,555
|
Accretion of series 8
preferred stock
|
|
-
|
|
6,237
|
|
-
|
|
6,785
|
Deemed dividend for the
modification Series 8 preferred stock
|
|
-
|
|
-
|
|
-
|
|
2,627
|
Deemed contribution for the
modification related to warrants issued in connection with the
Series 8 Preferred Stock
|
|
-
|
|
-
|
|
-
|
|
(1,469)
|
Amortization premium -
modification to Series 8 preferred stock
|
|
-
|
|
(1,252)
|
|
-
|
|
(1,362)
|
Distribution of equity method investment shares to employees as
compensation
|
|
-
|
|
-
|
|
666
|
|
-
|
Gain on equity
securities
|
|
(1,142)
|
|
-
|
|
(1,142)
|
|
-
|
Unrealized foreign
exchange (gains)/losses
|
|
28
|
|
35
|
|
(145)
|
|
124
|
Bad debts
expense/provision
|
|
24
|
|
-
|
|
24
|
|
-
|
Reserve for inventory
obsolescence
|
|
16
|
|
-
|
|
16
|
|
-
|
Stock-based
compensation - compensation and related benefits
|
|
241
|
|
741
|
|
570
|
|
2,274
|
Severance
costs
|
|
-
|
|
-
|
|
127
|
|
62
|
Amortization of
intangibles
|
|
230
|
|
563
|
|
449
|
|
1,078
|
Proforma non-GAAP net
loss
|
|
$ (6,911)
|
|
$
(5,248)
|
|
$
(16,231)
|
|
$
(11,860)
|
Proforma non-GAAP net
loss per basic and diluted common share
|
|
$
(0.18)
|
|
$
(2.72)
|
|
$
(0.79)
|
|
$ (5.88)
|
Weighted average basic
and diluted common shares outstanding
|
|
37,442,387
|
|
1,931,535
|
|
20,600,208
|
|
2,018,295
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inpixon-reports-second-quarter-2023-financial-results-and-provides-business-update-301899837.html
SOURCE Inpixon